nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—testicular cancer	0.769	0.908	CbGbCtD
Tetrabenazine—CYP2D6—Vinblastine—testicular cancer	0.0482	0.0569	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—testicular cancer	0.0296	0.035	CbGbCtD
Tetrabenazine—CBR1—Vincristine—Vinblastine—testicular cancer	0.00768	1	CbGdCrCtD
Tetrabenazine—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00649	0.402	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—SLC2A6—testicular cancer	0.00274	0.17	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00235	0.145	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00177	0.11	CbGpPWpGaD
Tetrabenazine—Agitation—Chlorambucil—testicular cancer	0.000945	0.00732	CcSEcCtD
Tetrabenazine—Irritability—Cisplatin—testicular cancer	0.000929	0.0072	CcSEcCtD
Tetrabenazine—Leukopenia—Chlorambucil—testicular cancer	0.00092	0.00713	CcSEcCtD
Tetrabenazine—Dysuria—Ifosfamide—testicular cancer	0.000913	0.00707	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Cisplatin—testicular cancer	0.000889	0.00689	CcSEcCtD
Tetrabenazine—Breast disorder—Cisplatin—testicular cancer	0.00088	0.00681	CcSEcCtD
Tetrabenazine—Confusional state—Chlorambucil—testicular cancer	0.000846	0.00655	CcSEcCtD
Tetrabenazine—Leukopenia—Vinblastine—testicular cancer	0.000843	0.00653	CcSEcCtD
Tetrabenazine—Blood disorder—Epirubicin—testicular cancer	0.000824	0.00639	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000805	0.0498	CbGpPWpGaD
Tetrabenazine—Bradycardia—Ifosfamide—testicular cancer	0.000795	0.00616	CcSEcCtD
Tetrabenazine—Dysarthria—Methotrexate—testicular cancer	0.000778	0.00603	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Ifosfamide—testicular cancer	0.000771	0.00597	CcSEcCtD
Tetrabenazine—Dysphagia—Etoposide—testicular cancer	0.000771	0.00597	CcSEcCtD
Tetrabenazine—Urethral disorder—Ifosfamide—testicular cancer	0.000766	0.00593	CcSEcCtD
Tetrabenazine—Blood disorder—Doxorubicin—testicular cancer	0.000763	0.00591	CcSEcCtD
Tetrabenazine—Eye disorder—Ifosfamide—testicular cancer	0.00073	0.00565	CcSEcCtD
Tetrabenazine—Decreased appetite—Chlorambucil—testicular cancer	0.000729	0.00565	CcSEcCtD
Tetrabenazine—Dysarthria—Epirubicin—testicular cancer	0.000728	0.00564	CcSEcCtD
Tetrabenazine—Cardiac disorder—Ifosfamide—testicular cancer	0.000725	0.00561	CcSEcCtD
Tetrabenazine—Fatigue—Chlorambucil—testicular cancer	0.000723	0.0056	CcSEcCtD
Tetrabenazine—Leukopenia—Bleomycin—testicular cancer	0.000712	0.00552	CcSEcCtD
Tetrabenazine—Angiopathy—Ifosfamide—testicular cancer	0.000709	0.00549	CcSEcCtD
Tetrabenazine—Gait disturbance—Epirubicin—testicular cancer	0.000706	0.00546	CcSEcCtD
Tetrabenazine—Feeling abnormal—Chlorambucil—testicular cancer	0.000691	0.00535	CcSEcCtD
Tetrabenazine—Bradycardia—Cisplatin—testicular cancer	0.000686	0.00531	CcSEcCtD
Tetrabenazine—Mental disorder—Ifosfamide—testicular cancer	0.000684	0.0053	CcSEcCtD
Tetrabenazine—Dysarthria—Doxorubicin—testicular cancer	0.000674	0.00522	CcSEcCtD
Tetrabenazine—Decreased appetite—Vinblastine—testicular cancer	0.000668	0.00518	CcSEcCtD
Tetrabenazine—Ecchymosis—Methotrexate—testicular cancer	0.000665	0.00515	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Cisplatin—testicular cancer	0.000665	0.00515	CcSEcCtD
Tetrabenazine—Leukopenia—Dactinomycin—testicular cancer	0.000664	0.00514	CcSEcCtD
Tetrabenazine—Body temperature increased—Chlorambucil—testicular cancer	0.000663	0.00514	CcSEcCtD
Tetrabenazine—Urethral disorder—Cisplatin—testicular cancer	0.00066	0.00511	CcSEcCtD
Tetrabenazine—Constipation—Vinblastine—testicular cancer	0.000657	0.00509	CcSEcCtD
Tetrabenazine—Confusional state—Bleomycin—testicular cancer	0.000655	0.00507	CcSEcCtD
Tetrabenazine—Gait disturbance—Doxorubicin—testicular cancer	0.000653	0.00506	CcSEcCtD
Tetrabenazine—Feeling abnormal—Vinblastine—testicular cancer	0.000634	0.00491	CcSEcCtD
Tetrabenazine—Eye disorder—Cisplatin—testicular cancer	0.000629	0.00487	CcSEcCtD
Tetrabenazine—Cardiac disorder—Cisplatin—testicular cancer	0.000625	0.00484	CcSEcCtD
Tetrabenazine—Agitation—Ifosfamide—testicular cancer	0.000625	0.00484	CcSEcCtD
Tetrabenazine—Ecchymosis—Epirubicin—testicular cancer	0.000623	0.00482	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Etoposide—testicular cancer	0.000609	0.00472	CcSEcCtD
Tetrabenazine—Leukopenia—Ifosfamide—testicular cancer	0.000609	0.00471	CcSEcCtD
Tetrabenazine—Hypotension—Bleomycin—testicular cancer	0.000607	0.0047	CcSEcCtD
Tetrabenazine—Urethral disorder—Etoposide—testicular cancer	0.000605	0.00468	CcSEcCtD
Tetrabenazine—Asthenia—Chlorambucil—testicular cancer	0.000602	0.00466	CcSEcCtD
Tetrabenazine—Dyspnoea—Bleomycin—testicular cancer	0.000579	0.00448	CcSEcCtD
Tetrabenazine—Eye disorder—Etoposide—testicular cancer	0.000577	0.00446	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—testicular cancer	0.000576	0.00446	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000575	0.00445	CcSEcCtD
Tetrabenazine—Diarrhoea—Chlorambucil—testicular cancer	0.000574	0.00445	CcSEcCtD
Tetrabenazine—Cardiac disorder—Etoposide—testicular cancer	0.000573	0.00443	CcSEcCtD
Tetrabenazine—Decreased appetite—Bleomycin—testicular cancer	0.000564	0.00437	CcSEcCtD
Tetrabenazine—Angiopathy—Etoposide—testicular cancer	0.00056	0.00433	CcSEcCtD
Tetrabenazine—Confusional state—Ifosfamide—testicular cancer	0.00056	0.00433	CcSEcCtD
Tetrabenazine—Asthenia—Vinblastine—testicular cancer	0.000552	0.00427	CcSEcCtD
Tetrabenazine—Tremor—Cisplatin—testicular cancer	0.000549	0.00425	CcSEcCtD
Tetrabenazine—Nervous system disorder—Ifosfamide—testicular cancer	0.000544	0.00421	CcSEcCtD
Tetrabenazine—Skin disorder—Ifosfamide—testicular cancer	0.000539	0.00417	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Ifosfamide—testicular cancer	0.000536	0.00415	CcSEcCtD
Tetrabenazine—Feeling abnormal—Bleomycin—testicular cancer	0.000535	0.00414	CcSEcCtD
Tetrabenazine—Osteoarthritis—Methotrexate—testicular cancer	0.000534	0.00414	CcSEcCtD
Tetrabenazine—Vomiting—Chlorambucil—testicular cancer	0.000533	0.00413	CcSEcCtD
Tetrabenazine—Decreased appetite—Dactinomycin—testicular cancer	0.000526	0.00408	CcSEcCtD
Tetrabenazine—Diarrhoea—Vinblastine—testicular cancer	0.000526	0.00407	CcSEcCtD
Tetrabenazine—Leukopenia—Cisplatin—testicular cancer	0.000525	0.00406	CcSEcCtD
Tetrabenazine—Fatigue—Dactinomycin—testicular cancer	0.000522	0.00404	CcSEcCtD
Tetrabenazine—Hypotension—Ifosfamide—testicular cancer	0.000519	0.00402	CcSEcCtD
Tetrabenazine—Body temperature increased—Bleomycin—testicular cancer	0.000513	0.00398	CcSEcCtD
Tetrabenazine—Irritability—Methotrexate—testicular cancer	0.00051	0.00395	CcSEcCtD
Tetrabenazine—Dizziness—Vinblastine—testicular cancer	0.000508	0.00394	CcSEcCtD
Tetrabenazine—Ataxia—Methotrexate—testicular cancer	0.000502	0.00389	CcSEcCtD
Tetrabenazine—Osteoarthritis—Epirubicin—testicular cancer	0.0005	0.00387	CcSEcCtD
Tetrabenazine—Feeling abnormal—Dactinomycin—testicular cancer	0.000499	0.00386	CcSEcCtD
Tetrabenazine—Nausea—Chlorambucil—testicular cancer	0.000498	0.00386	CcSEcCtD
Tetrabenazine—Anxiety—Cisplatin—testicular cancer	0.000497	0.00385	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000496	0.00384	CcSEcCtD
Tetrabenazine—Dyspnoea—Ifosfamide—testicular cancer	0.000495	0.00383	CcSEcCtD
Tetrabenazine—Somnolence—Ifosfamide—testicular cancer	0.000493	0.00382	CcSEcCtD
Tetrabenazine—Vomiting—Vinblastine—testicular cancer	0.000489	0.00379	CcSEcCtD
Tetrabenazine—Breast disorder—Methotrexate—testicular cancer	0.000483	0.00374	CcSEcCtD
Tetrabenazine—Decreased appetite—Ifosfamide—testicular cancer	0.000482	0.00374	CcSEcCtD
Tetrabenazine—Headache—Vinblastine—testicular cancer	0.000482	0.00373	CcSEcCtD
Tetrabenazine—Leukopenia—Etoposide—testicular cancer	0.000481	0.00372	CcSEcCtD
Tetrabenazine—Body temperature increased—Dactinomycin—testicular cancer	0.000479	0.00371	CcSEcCtD
Tetrabenazine—Fatigue—Ifosfamide—testicular cancer	0.000478	0.00371	CcSEcCtD
Tetrabenazine—Constipation—Ifosfamide—testicular cancer	0.000475	0.00368	CcSEcCtD
Tetrabenazine—Ataxia—Epirubicin—testicular cancer	0.00047	0.00364	CcSEcCtD
Tetrabenazine—Nervous system disorder—Cisplatin—testicular cancer	0.000469	0.00363	CcSEcCtD
Tetrabenazine—Asthenia—Bleomycin—testicular cancer	0.000466	0.00361	CcSEcCtD
Tetrabenazine—Skin disorder—Cisplatin—testicular cancer	0.000465	0.0036	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—testicular cancer	0.000463	0.00358	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Cisplatin—testicular cancer	0.000463	0.00358	CcSEcCtD
Tetrabenazine—Feeling abnormal—Ifosfamide—testicular cancer	0.000457	0.00354	CcSEcCtD
Tetrabenazine—Nausea—Vinblastine—testicular cancer	0.000457	0.00354	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Epirubicin—testicular cancer	0.000457	0.00354	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Epirubicin—testicular cancer	0.000457	0.00354	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000454	0.00352	CcSEcCtD
Tetrabenazine—Breast disorder—Epirubicin—testicular cancer	0.000452	0.0035	CcSEcCtD
Tetrabenazine—Hypotension—Cisplatin—testicular cancer	0.000447	0.00346	CcSEcCtD
Tetrabenazine—Confusional state—Etoposide—testicular cancer	0.000442	0.00342	CcSEcCtD
Tetrabenazine—Body temperature increased—Ifosfamide—testicular cancer	0.000439	0.0034	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—testicular cancer	0.000435	0.00337	CcSEcCtD
Tetrabenazine—Asthenia—Dactinomycin—testicular cancer	0.000434	0.00336	CcSEcCtD
Tetrabenazine—Dysphagia—Epirubicin—testicular cancer	0.000432	0.00335	CcSEcCtD
Tetrabenazine—Dysuria—Methotrexate—testicular cancer	0.000432	0.00334	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000429	0.00332	CcSEcCtD
Tetrabenazine—Dyspnoea—Cisplatin—testicular cancer	0.000427	0.0033	CcSEcCtD
Tetrabenazine—Skin disorder—Etoposide—testicular cancer	0.000426	0.0033	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Etoposide—testicular cancer	0.000424	0.00328	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000422	0.00327	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—testicular cancer	0.000422	0.00327	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—testicular cancer	0.000418	0.00324	CcSEcCtD
Tetrabenazine—Decreased appetite—Cisplatin—testicular cancer	0.000416	0.00322	CcSEcCtD
Tetrabenazine—Bronchitis—Epirubicin—testicular cancer	0.000415	0.00322	CcSEcCtD
Tetrabenazine—Diarrhoea—Dactinomycin—testicular cancer	0.000414	0.00321	CcSEcCtD
Tetrabenazine—Vomiting—Bleomycin—testicular cancer	0.000413	0.0032	CcSEcCtD
Tetrabenazine—Drowsiness—Methotrexate—testicular cancer	0.000412	0.00319	CcSEcCtD
Tetrabenazine—Depression—Methotrexate—testicular cancer	0.00041	0.00318	CcSEcCtD
Tetrabenazine—Hypotension—Etoposide—testicular cancer	0.00041	0.00317	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000409	0.0253	CbGpPWpGaD
Tetrabenazine—Dysuria—Epirubicin—testicular cancer	0.000404	0.00313	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000402	0.00311	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—testicular cancer	0.0004	0.0031	CcSEcCtD
Tetrabenazine—Asthenia—Ifosfamide—testicular cancer	0.000398	0.00308	CcSEcCtD
Tetrabenazine—Sweating—Methotrexate—testicular cancer	0.000395	0.00306	CcSEcCtD
Tetrabenazine—Feeling abnormal—Cisplatin—testicular cancer	0.000394	0.00305	CcSEcCtD
Tetrabenazine—Dyspnoea—Etoposide—testicular cancer	0.000391	0.00303	CcSEcCtD
Tetrabenazine—Somnolence—Etoposide—testicular cancer	0.00039	0.00302	CcSEcCtD
Tetrabenazine—Nausea—Bleomycin—testicular cancer	0.000386	0.00299	CcSEcCtD
Tetrabenazine—Drowsiness—Epirubicin—testicular cancer	0.000385	0.00298	CcSEcCtD
Tetrabenazine—Vomiting—Dactinomycin—testicular cancer	0.000385	0.00298	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—testicular cancer	0.000384	0.00298	CcSEcCtD
Tetrabenazine—Decreased appetite—Etoposide—testicular cancer	0.000381	0.00295	CcSEcCtD
Tetrabenazine—Diarrhoea—Ifosfamide—testicular cancer	0.00038	0.00294	CcSEcCtD
Tetrabenazine—Body temperature increased—Cisplatin—testicular cancer	0.000378	0.00293	CcSEcCtD
Tetrabenazine—Fatigue—Etoposide—testicular cancer	0.000378	0.00293	CcSEcCtD
Tetrabenazine—Constipation—Etoposide—testicular cancer	0.000375	0.0029	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—testicular cancer	0.000374	0.00289	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000372	0.00288	CcSEcCtD
Tetrabenazine—Sweating—Epirubicin—testicular cancer	0.000369	0.00286	CcSEcCtD
Tetrabenazine—Dizziness—Ifosfamide—testicular cancer	0.000367	0.00284	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Methotrexate—testicular cancer	0.000365	0.00283	CcSEcCtD
Tetrabenazine—Urethral disorder—Methotrexate—testicular cancer	0.000362	0.00281	CcSEcCtD
Tetrabenazine—Feeling abnormal—Etoposide—testicular cancer	0.000361	0.0028	CcSEcCtD
Tetrabenazine—Nausea—Dactinomycin—testicular cancer	0.00036	0.00279	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—testicular cancer	0.000356	0.00276	CcSEcCtD
Tetrabenazine—Vomiting—Ifosfamide—testicular cancer	0.000353	0.00273	CcSEcCtD
Tetrabenazine—Bradycardia—Epirubicin—testicular cancer	0.000352	0.00273	CcSEcCtD
Tetrabenazine—Body temperature increased—Etoposide—testicular cancer	0.000346	0.00268	CcSEcCtD
Tetrabenazine—Eye disorder—Methotrexate—testicular cancer	0.000345	0.00267	CcSEcCtD
Tetrabenazine—Asthenia—Cisplatin—testicular cancer	0.000343	0.00266	CcSEcCtD
Tetrabenazine—Cardiac disorder—Methotrexate—testicular cancer	0.000343	0.00266	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—testicular cancer	0.000342	0.00265	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—testicular cancer	0.000342	0.00264	CcSEcCtD
Tetrabenazine—Urethral disorder—Epirubicin—testicular cancer	0.000339	0.00263	CcSEcCtD
Tetrabenazine—Angiopathy—Methotrexate—testicular cancer	0.000335	0.0026	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000335	0.0207	CbGpPWpGaD
Tetrabenazine—Nausea—Ifosfamide—testicular cancer	0.00033	0.00255	CcSEcCtD
Tetrabenazine—Diarrhoea—Cisplatin—testicular cancer	0.000327	0.00254	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—testicular cancer	0.000326	0.00252	CcSEcCtD
Tetrabenazine—Mental disorder—Methotrexate—testicular cancer	0.000324	0.00251	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—testicular cancer	0.000323	0.0025	CcSEcCtD
Tetrabenazine—Cardiac disorder—Epirubicin—testicular cancer	0.000321	0.00249	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000316	0.00245	CcSEcCtD
Tetrabenazine—Asthenia—Etoposide—testicular cancer	0.000314	0.00244	CcSEcCtD
Tetrabenazine—Angiopathy—Epirubicin—testicular cancer	0.000314	0.00243	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—testicular cancer	0.000314	0.00243	CcSEcCtD
Tetrabenazine—Vomiting—Cisplatin—testicular cancer	0.000304	0.00236	CcSEcCtD
Tetrabenazine—Mental disorder—Epirubicin—testicular cancer	0.000303	0.00235	CcSEcCtD
Tetrabenazine—Diarrhoea—Etoposide—testicular cancer	0.0003	0.00232	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—testicular cancer	0.000299	0.00232	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—testicular cancer	0.000297	0.0023	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—testicular cancer	0.000295	0.00229	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—testicular cancer	0.000292	0.00226	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—testicular cancer	0.00029	0.00225	CcSEcCtD
Tetrabenazine—Dizziness—Etoposide—testicular cancer	0.00029	0.00224	CcSEcCtD
Tetrabenazine—Leukopenia—Methotrexate—testicular cancer	0.000288	0.00223	CcSEcCtD
Tetrabenazine—Nausea—Cisplatin—testicular cancer	0.000284	0.0022	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—testicular cancer	0.00028	0.00217	CcSEcCtD
Tetrabenazine—Vomiting—Etoposide—testicular cancer	0.000279	0.00216	CcSEcCtD
Tetrabenazine—Agitation—Epirubicin—testicular cancer	0.000277	0.00214	CcSEcCtD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000275	0.017	CbGpPWpGaD
Tetrabenazine—Headache—Etoposide—testicular cancer	0.000275	0.00213	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—testicular cancer	0.000273	0.00212	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000272	0.00211	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—testicular cancer	0.000271	0.0021	CcSEcCtD
Tetrabenazine—Leukopenia—Epirubicin—testicular cancer	0.000269	0.00209	CcSEcCtD
Tetrabenazine—Confusional state—Methotrexate—testicular cancer	0.000265	0.00205	CcSEcCtD
Tetrabenazine—Nausea—Etoposide—testicular cancer	0.00026	0.00202	CcSEcCtD
Tetrabenazine—Nervous system disorder—Methotrexate—testicular cancer	0.000257	0.00199	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—testicular cancer	0.000256	0.00198	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—testicular cancer	0.000255	0.00198	CcSEcCtD
Tetrabenazine—Skin disorder—Methotrexate—testicular cancer	0.000255	0.00197	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000255	0.00197	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Methotrexate—testicular cancer	0.000254	0.00197	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—testicular cancer	0.000251	0.00194	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—testicular cancer	0.000249	0.00193	CcSEcCtD
Tetrabenazine—Confusional state—Epirubicin—testicular cancer	0.000248	0.00192	CcSEcCtD
Tetrabenazine—Hypotension—Methotrexate—testicular cancer	0.000245	0.0019	CcSEcCtD
Tetrabenazine—Nervous system disorder—Epirubicin—testicular cancer	0.000241	0.00187	CcSEcCtD
Tetrabenazine—Skin disorder—Epirubicin—testicular cancer	0.000239	0.00185	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Epirubicin—testicular cancer	0.000238	0.00184	CcSEcCtD
Tetrabenazine—Insomnia—Methotrexate—testicular cancer	0.000237	0.00184	CcSEcCtD
Tetrabenazine—Anxiety—Doxorubicin—testicular cancer	0.000236	0.00183	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000236	0.00182	CcSEcCtD
Tetrabenazine—Dyspnoea—Methotrexate—testicular cancer	0.000234	0.00181	CcSEcCtD
Tetrabenazine—Somnolence—Methotrexate—testicular cancer	0.000233	0.00181	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—testicular cancer	0.000232	0.0018	CcSEcCtD
Tetrabenazine—Hypotension—Epirubicin—testicular cancer	0.00023	0.00178	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—testicular cancer	0.000229	0.00178	CcSEcCtD
Tetrabenazine—Decreased appetite—Methotrexate—testicular cancer	0.000228	0.00177	CcSEcCtD
Tetrabenazine—Fatigue—Methotrexate—testicular cancer	0.000226	0.00175	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—testicular cancer	0.000223	0.00173	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—testicular cancer	0.000222	0.00172	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—testicular cancer	0.000221	0.00171	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00022	0.0017	CcSEcCtD
Tetrabenazine—Dyspnoea—Epirubicin—testicular cancer	0.000219	0.0017	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—testicular cancer	0.000218	0.00169	CcSEcCtD
Tetrabenazine—Feeling abnormal—Methotrexate—testicular cancer	0.000216	0.00168	CcSEcCtD
Tetrabenazine—Decreased appetite—Epirubicin—testicular cancer	0.000214	0.00165	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—testicular cancer	0.000212	0.00165	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—testicular cancer	0.000212	0.00164	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—testicular cancer	0.00021	0.00163	CcSEcCtD
Tetrabenazine—DRD2—GPCR ligand binding—INSL3—testicular cancer	0.00021	0.013	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Methotrexate—testicular cancer	0.000208	0.00161	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—testicular cancer	0.000206	0.00159	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—testicular cancer	0.000203	0.00157	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—testicular cancer	0.000202	0.00157	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—testicular cancer	0.000202	0.00157	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—testicular cancer	0.000198	0.00153	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—testicular cancer	0.000196	0.00152	CcSEcCtD
Tetrabenazine—Constipation—Doxorubicin—testicular cancer	0.000194	0.00151	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—testicular cancer	0.000194	0.0015	CcSEcCtD
Tetrabenazine—Asthenia—Methotrexate—testicular cancer	0.000188	0.00146	CcSEcCtD
Tetrabenazine—Feeling abnormal—Doxorubicin—testicular cancer	0.000187	0.00145	CcSEcCtD
Tetrabenazine—Body temperature increased—Doxorubicin—testicular cancer	0.00018	0.00139	CcSEcCtD
Tetrabenazine—Diarrhoea—Methotrexate—testicular cancer	0.00018	0.00139	CcSEcCtD
Tetrabenazine—Asthenia—Epirubicin—testicular cancer	0.000176	0.00137	CcSEcCtD
Tetrabenazine—Dizziness—Methotrexate—testicular cancer	0.000174	0.00134	CcSEcCtD
Tetrabenazine—Diarrhoea—Epirubicin—testicular cancer	0.000168	0.0013	CcSEcCtD
Tetrabenazine—Vomiting—Methotrexate—testicular cancer	0.000167	0.00129	CcSEcCtD
Tetrabenazine—Headache—Methotrexate—testicular cancer	0.000164	0.00127	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—testicular cancer	0.000163	0.00126	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—testicular cancer	0.000162	0.00126	CcSEcCtD
Tetrabenazine—Vomiting—Epirubicin—testicular cancer	0.000156	0.00121	CcSEcCtD
Tetrabenazine—Nausea—Methotrexate—testicular cancer	0.000156	0.00121	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—testicular cancer	0.000156	0.0012	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—testicular cancer	0.000154	0.00119	CcSEcCtD
Tetrabenazine—Dizziness—Doxorubicin—testicular cancer	0.00015	0.00116	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—HPGDS—testicular cancer	0.000149	0.00923	CbGpPWpGaD
Tetrabenazine—Nausea—Epirubicin—testicular cancer	0.000146	0.00113	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—testicular cancer	0.000145	0.00112	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—testicular cancer	0.000142	0.0011	CcSEcCtD
Tetrabenazine—Nausea—Doxorubicin—testicular cancer	0.000135	0.00105	CcSEcCtD
Tetrabenazine—DRD2—GPCR downstream signaling—INSL3—testicular cancer	0.000118	0.00732	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	0.000114	0.00702	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—STK11—testicular cancer	0.000108	0.00671	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—INSL3—testicular cancer	0.000108	0.00665	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INSL3—testicular cancer	6.35e-05	0.00393	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	2.03e-05	0.00126	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STK11—testicular cancer	2.02e-05	0.00125	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPGDS—testicular cancer	1.94e-05	0.0012	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KITLG—testicular cancer	1.87e-05	0.00116	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STK11—testicular cancer	1.41e-05	0.000872	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR3—testicular cancer	1.39e-05	0.00086	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KIT—testicular cancer	1.28e-05	0.000789	CbGpPWpGaD
